Fibroids and Black Women: Why Risk Runs Higher
SaveBlack women develop fibroids roughly two to three times as often as other women, and typically earlier, larger, and with heavier symptoms. The reasons blend genetics, vitamin D, and hormonal factors, compounded by delayed diagnosis. Knowing the full range of uterus-sparing options helps you advocate for the right treatment.
Last updated: July 2026History
How much more common are fibroids in Black women?
Black women carry a strikingly higher fibroid burden than any other group studied. By age 50, roughly 8 in 10 Black women develop fibroids, compared with about 7 in 10 White women, and symptom-causing disease runs about 2 to 3 times higher 1Ref 1American College of Obstetricians and Gynecologists (2021).Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered.. Fibroids also tend to appear earlier — often in the 20s and 30s — and to be larger and more numerous when found 3Ref 3Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017).Management of Uterine Fibroids (Comparative Effectiveness Review No. 195).Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.. According to the American College of Obstetricians and Gynecologists, this makes fibroids one of the most pronounced racial disparities in gynecology 1Ref 1American College of Obstetricians and Gynecologists (2021).Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered.. The numbers are not abstract: they translate into more years of heavy bleeding, pain, and pressure, and into higher rates of hysterectomy.
Why does the risk run higher?
Researchers have not pinned down a single cause, and the honest answer is that several factors likely combine. Genetics play a real role — fibroids cluster in families, and heritability is well documented — but genes alone do not explain the gap 3Ref 3Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017).Management of Uterine Fibroids (Comparative Effectiveness Review No. 195).Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.. Lower vitamin D levels, which are more common in people with more melanin because skin pigment reduces vitamin D made from sunlight, have been linked to higher fibroid risk in several studies 1Ref 1American College of Obstetricians and Gynecologists (2021).Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered.. Hormonal and reproductive factors, early-life exposures, and chronic stress tied to racism are also under investigation. Importantly, structural factors — less access to timely care and to specialists — do not cause fibroids, but they do let fibroids grow larger and more symptomatic before treatment 3Ref 3Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017).Management of Uterine Fibroids (Comparative Effectiveness Review No. 195).Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.. No single gene or exposure explains the whole gap, which is why the research continues.
How does the disease tend to differ?
Fibroids in Black women often follow a more aggressive course across the lifespan. Because they frequently start in the 20s and 30s, fibroids may grow for 15 to 20 years before menopause, which can mean worse heavy menstrual bleeding, anemia, and pressure symptoms by midlife 3Ref 3Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017).Management of Uterine Fibroids (Comparative Effectiveness Review No. 195).Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.. Like all fibroids, they usually shrink within about 3 years of menopause, but the earlier onset means a longer stretch of symptoms beforehand 1Ref 1American College of Obstetricians and Gynecologists (2021).Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered.. Larger and more numerous fibroids can also narrow the surgical choices, sometimes pushing toward hysterectomy when a uterus-sparing option might otherwise have worked. Recognizing symptoms early, using resources on how to tell if you have fibroids, can shift that timeline.
How can you advocate for full treatment options?
Advocating for yourself starts with knowing that hysterectomy is rarely the only option, even for large or multiple fibroids. Uterus-sparing choices — medicines, embolization, and myomectomy detailed in our guide to uterine fibroids treatment — are appropriate for many women, and guidelines encourage offering them before defaulting to removal of the uterus 2Ref 2National Institute for Health and Care Excellence (2026).Heavy menstrual bleeding: assessment and management (NG88).Guideline emphasis on offering the full range of uterus-sparing treatments and shared decision-making driven by a woman's priorities before defaulting to hysterectomy.. Asking directly which options preserve fertility, and requesting a referral to a fibroid specialist, can widen a narrow-sounding plan. According to shared decision-making guidance, your priorities — fertility, symptom relief, recovery time — should steer the choice 2Ref 2National Institute for Health and Care Excellence (2026).Heavy menstrual bleeding: assessment and management (NG88).Guideline emphasis on offering the full range of uterus-sparing treatments and shared decision-making driven by a woman's priorities before defaulting to hysterectomy.. Bringing a symptom diary and a clear list of questions helps make sure your goals are heard. Framing the conversation around what you want to preserve tends to open up more options.
When heavy bleeding from fibroids needs a clinician
A clinician who takes your symptoms seriously can confirm the diagnosis, gauge fibroid size and number, and lay out the full range of treatments rather than a single default. Because Black women face fibroids earlier and about two to three times more often 1Ref 1American College of Obstetricians and Gynecologists (2021).Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered., starting the conversation early — rather than normalizing years of heavy bleeding — protects both your health and your options 3Ref 3Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017).Management of Uterine Fibroids (Comparative Effectiveness Review No. 195).Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.. Because most fibroids can be treated without removing the uterus, a second opinion is always reasonable 2Ref 2National Institute for Health and Care Excellence (2026).Heavy menstrual bleeding: assessment and management (NG88).Guideline emphasis on offering the full range of uterus-sparing treatments and shared decision-making driven by a woman's priorities before defaulting to hysterectomy.. Bringing a record of your bleeding, pain, and pressure, along with your fertility wishes, turns that visit into a real plan. Gale can help you organize those notes and questions beforehand.
Common questions
Related
Hormonal health
Fibroid Ablation and Focused Ultrasound: New OptionsHormonal health
Castor Oil Packs and Fibroids: Checking the ClaimsHormonal health
Myomectomy vs Hysterectomy: Choosing Fibroid Surgery
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
Fibroid symptoms that warrant care
- —Heavy bleeding with fatigue, dizziness, breathlessness, or a racing heart is a reason to seek urgent evaluation for anemia
- —Bleeding that soaks through a pad or tampon every hour for several hours is a reason to seek same-day care
- —Severe pelvic pain or rapid abdominal swelling is a reason to seek prompt clinician review
- —Being told hysterectomy is the only option without discussion of alternatives is a reason to seek a second opinion
This article is general health education, not medical advice. Diagnosis and treatment of fibroids should be guided by a gynecologist or other clinician who can examine you, review imaging, and discuss the full range of options.
Did this answer your question?
References
- 1.American College of Obstetricians and Gynecologists (2021). Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000004401 ✓Guidance documenting higher fibroid prevalence and severity in Black women (roughly two- to threefold), earlier onset, the vitamin D association, and racial disparities in leiomyoma care and treatment offered.
- 2.National Institute for Health and Care Excellence (2026). Heavy menstrual bleeding: assessment and management (NG88). National Institute for Health and Care Excellence (NICE). link ✓Guideline emphasis on offering the full range of uterus-sparing treatments and shared decision-making driven by a woman's priorities before defaulting to hysterectomy.
- 3.Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017). Management of Uterine Fibroids (Comparative Effectiveness Review No. 195). Agency for Healthcare Research and Quality (AHRQ). PMID 30789683 ✓Comparative-effectiveness evidence on fibroid epidemiology, earlier onset and larger or more numerous fibroids, familial clustering, and how access and disease features shape treatment options.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy